| Case report: Fulminant celiac disease with combination immune checkpoint therapy AS Falade, KL Reynolds, L Zubiri, V Deshpande, FJ Fintelmann, ... Frontiers in immunology 13, 871452, 2022 | 8 | 2022 |
| PD-1 Blockade before Autologous Stem Cell Transplantation Improves Outcomes in Relapsed/Refractory Classic Hodgkin Lymphoma: Results from a Multicenter Cohort SH Desai, RW Merryman, H Shah, LD Pederson, SM Geyer, N Ganesan, ... Blood 142, 182, 2023 | 3 | 2023 |
| Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and … AS Falade, RA Redd, H Shah, K Baron, S Iyengar, SH Desai, SM Ansell, ... Blood 142, 3062, 2023 | 2 | 2023 |
| Outcomes for Patients with Classical Hodgkin Lymphoma Who Relapse after Autologous Stem Cell Transplant in the Era of Novel Therapies R Stuver, E Drill, N Ganesan, K Baron, E Casper, T Chang, SH Desai, ... Blood 142, 3069, 2023 | 1 | 2023 |
| Real-World Outcomes of CD19CAR T Cell Therapy in Adult Patients with Relapsed Refractory Transformed Indolent Lymphoma S Kambhampati, RW Merryman, Y Wang, E Bezerra, T Voorhees, ... Blood 142, 3511, 2023 | 1 | 2023 |
| Immune checkpoint inhibitor (ICI) rechallenge after immune-related adverse events (irAE) requiring hospitalization: A single-center 10-year experience. CY Wu, L Zubiri, SJ Rouhani, RD Merkin, A Holt, AS Falade, K Grealish, ... Journal of Clinical Oncology 42 (16_suppl), e14609-e14609, 2024 | | 2024 |
| Patient and caregiver experience with the hope and prognostic uncertainty of immunotherapy: A qualitative study. MC Boulanger, AS Falade, K Hsu, R Sommer, A Zhou, R Sarathy, ... Journal of Clinical Oncology 42 (16_suppl), 12010-12010, 2024 | | 2024 |
| Outcomes of Patients with ALK+ Anaplastic Large Cell Lymphoma Refractory or Relapsed after Frontline Chemotherapy M Sorrell, A Ip, R Stuver, GL Shah, A Crawford, D Jagadeesh, B Matia, ... Transplantation and Cellular Therapy 30 (2), S363-S364, 2024 | | 2024 |
| Impact of Peri-Transplant Radiation on Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant K Baron, E Drill, N Ganesan, RW Merryman, MG Mei, R Stuver, SH Desai, ... Blood 142, 4436, 2023 | | 2023 |
| Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Refractory or Relapsed after Frontline R-EPOCH Chemotherapy J Bakos, SE Serrat, Y Sawalha, A Moskowitz, A Crawford, TR Brooks, ... Blood 142, 3110, 2023 | | 2023 |
| Learning about and living with toxicity: A qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers. AS Falade, K Hsu, R Fadden, KL Reynolds, JS Temel, JA Greer, ... JCO Oncology Practice 19 (11_suppl), 297-297, 2023 | | 2023 |
| Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis NA Krasnow, DF Chute, AS Falade, CM North, KL Reynolds, ML Dougan Immunotherapy 15 (12), 913-920, 2023 | | 2023 |
| Clinical Trials in Gastroesophageal Cancers: An Analysis of the Global Landscape of Interventional Trials From ClinicalTrials. gov A Falade, O Adeoye, G Buckle Cancer Epidemiology, Biomarkers & Prevention 32 (6_Supplement), 21-21, 2023 | | 2023 |
| 1253 Retrospective analysis of immunotherapy toxicities requiring hospitalization in lung cancer patients A Falade, L Zubiri, K Reynolds, M Mooradian Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| treatment support, quality of life and self-reported adherence to antiretroviral therapy among HIV positive patients in state specialist hospital Akure, Ondo-state AF Tayelolu Odesanmi ESC Abstract Book 2020 16 (13-15 May, 2020), Abstract P-151, 2020 | | 2020 |
| Management of patients with acute lymphoblastic leukemia AS Falade, SAS Belal, EA Liuta, AS Litvin Вестник Харьковского национального университета имени ВН Каразина. Серия …, 2017 | | 2017 |
| The role of culture and religion on reproduction and sexuality in Ukraine A Falade, E Ajayi The European Journal of Contraception and Reproductive Health Care, 88, 0 | | |
